Brief: Immunovia Appoints Philipp Mathieu As Acting CEO
Jan 20 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA APPOINTS PHILIPP MATHIEU AS ACTING CEO
* ANNOUNCES THAT PHILIPP MATHIEU HAS BEEN APPOINTED ACTING
CEO AND
PRESIDENT WITH IMMEDIATE EFFECT.
* SEARCH FOR A PERMANENT CEO CONTINUES, AS PREVIOUSLY
COMMUNICATED.
Source text for Eikon: ID:nWkr43n4d9
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study